Compugen
CGEN
Compugen (CGEN) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Leerink Partners | Maintained | Outperform | $5.00 from $13.00 | May 21, 2026 |
| Lake Street | Initiated Coverage | Buy | $6.00 | Apr 7, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $4.00 | Jan 7, 2026 |
| Truist Securities | Maintained | Buy | $4.00 from $5.00 | May 21, 2024 |
| Truist Securities | Maintained | Buy | $5.00 from $4.00 | Mar 8, 2024 |
| Stifel | Maintained | Buy | $4.00 from $3.00 | Dec 19, 2023 |
| Truist Securities | Maintained | Buy | $4.00 | Aug 23, 2023 |
| EF Hutton | Maintained | Buy | $13.00 | Aug 7, 2023 |
| EF Hutton | Maintained | Buy | $13.00 | Jun 6, 2023 |
| EF Hutton | Maintained | Buy | $13.00 | May 26, 2023 |
| EF Hutton | Maintained | Buy | $13.00 | May 24, 2023 |
| Oppenheimer | Maintained | Outperform | $7.00 from $8.00 | May 16, 2023 |
Frequently asked questions
What is the latest analyst rating on CGEN?
On May 21, 2026, Leerink Partners maintained Compugen at Outperform with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.